RBF Capital, LLC - PIERIS PHARMACEUTICALS INC ownership

PIERIS PHARMACEUTICALS INC's ticker is PIRS and the CUSIP is 720795103. A total of 116 filers reported holding PIERIS PHARMACEUTICALS INC in Q1 2018. The put-call ratio across all filers is 4.49 and the average weighting 0.1%.

Quarter-by-quarter ownership
RBF Capital, LLC ownership history of PIERIS PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2020$114,000
-43.6%
50,000
-10.7%
0.02%
-21.1%
Q4 2019$202,000
+5.8%
56,0000.0%0.02%
-9.5%
Q3 2019$191,000
-27.4%
56,0000.0%0.02%
-19.2%
Q2 2019$263,000
+32.8%
56,000
-5.4%
0.03%
+13.0%
Q1 2019$198,000
-73.5%
59,189
-78.9%
0.02%
-76.5%
Q4 2018$747,000
+295.2%
281,000
+1024.0%
0.10%
+366.7%
Q4 2017$189,000
+21.9%
25,0000.0%0.02%
+5.0%
Q3 2017$155,000
+22.0%
25,0000.0%0.02%
+17.6%
Q2 2017$127,000
+95.4%
25,0000.0%0.02%
+88.9%
Q1 2017$65,000
+44.4%
25,0000.0%0.01%
+50.0%
Q4 2016$45,00025,0000.01%
Other shareholders
PIERIS PHARMACEUTICALS INC shareholders Q1 2018
NameSharesValueWeighting ↓
Lynx1 Capital Management LP 9,775,849$2,913,2031.93%
Aquilo Capital Management, LLC 3,303,190$984,3510.89%
CM Management, LLC 649,400$193,5210.20%
BVF INC/IL 20,609,863$6,141,7390.17%
WEALTH EFFECTS LLC 11,700$3,4870.00%
NJ State Employees Deferred Compensation Plan 30,000$8,9400.00%
HUDSON VALLEY INVESTMENT ADVISORS INC /ADV 14,000$4,1720.00%
ACADIAN ASSET MANAGEMENT LLC 962,358$2860.00%
TWO SIGMA ADVISERS, LP 24,400$7,2710.00%
Tower View Wealth Management LLC 1,000$00.00%
View complete list of PIERIS PHARMACEUTICALS INC shareholders